Company news
Cannabis Bioscience International Holdings, Inc. (OTC:CBIH) news
Cannabis Bioscience International Holdings, Inc. news releases on 6ix. Latest, Apr 1, 2022: A letter from the desk of CHNC’s CEO…
Press releases — page 2
A letter from the desk of CHNC’s CEO…
March 31, 2022
CHNC Announces Return of Half a Billion Shares
March 28, 2022
CHNC Announces Completion of Audited Financial Statements
March 23, 2022
CHNC - Alpha Research Institute Update
November 29, 2021
CHNC Continues to Position Itself as Colombia’s Quintessential Medical Cannabis Educator
November 22, 2021
CHNC Announces New Relationship with a Houston, Texas-based Professional PCAOB Accounting Firm
November 17, 2021
CHNC Seeks To Continue To Bring Medical Cannabis Education To The Middle East With New Brand Ambassador
November 5, 2021
CHNC Ventures Into Latin American Country for Extension of Its Clinical Research Facilities
October 25, 2021
CHNC Announces a New Member of Its Board of Directors
October 20, 2021
CHNC Endeavors in Artificial Intelligence Systems for Its Educational Content
October 18, 2021
CHNC to Seek Up to $3 Million Funding for Expansion of Existing Product Lines and Development of New Cannabis-Derived Therapeutics
October 1, 2021
CHNC's Shareholders Rewarded with Astonishing Investment Return of Over 2500% During this Last Year
September 22, 2021
CHNC Expands Distribution of Its Educational Training Programs Through Leading Online Digital Distributors
September 10, 2021
CHNC Announces Name Change to Cannabis Bioscience International Holdings, Inc.
June 14, 2021
CHNC: Intensity, Determination and a Magical Unwavering Direction Transports CHNC to Become the Macondo of Medical Cannabis Research
March 17, 2021
CHNC Saga, Metamorphosis, and Transformation
February 5, 2021
CHNC Publishes Its Phytotherapy Project With Cannabinoids That Seeks to Attack the Effects of COVID-19
November 18, 2020
CHNC Aims to be the Global Leader in Cannabis Clinical Trials Through a Merger with Pharmacology University
October 28, 2020
China Infrastructure Construction Corp. (OTCPK: CHNC) is Pleased to Announce its Acquisition of Precision Research Institute, LLC (PRI)
October 21, 2019
China Infrastructure Construction Corp. (OTCPK: CHNC) Explores an Acquisition Opportunity in Stem Cell Space
March 6, 2019
China Infrastructure Construction Corp. (OTCPK: CHNC) Opens HOUSTON STEM CELLS CLINIC, INC.
February 20, 2019
China Infrastructure Construction Corp. (OTCPK: CHNC) Explores STEM CELL Opportunity
February 12, 2019
China Infrastructure Construction Corp. (OTCPK: CHNC) Names World-Renowned Plastic Surgeon Dr. Andrew Lyos, M.D. as Surgical Director of Hippocrates Direct Healthcare Inc.
November 14, 2018
China Infrastructure Construction Corp. (OTCPK: CHNC) Names World-Renowned Dr. L. Natalie Carroll, M.D. as Medical Director of Hippocrates Direct Healthcare, Inc.’s Flagship Location
October 22, 2018
China Infrastructure Construction Corp. (OTCPK: CHNC) and America’s Advanced Wellness Centers, LLC (AAWC) Enter Into Acquisition Agreement
October 18, 2018
China Infrastructure Construction Corp. (OTCPK: CHNC) Announces That It Has Qualified to OTC PINK Classification
July 26, 2018
China Infrastructure Construction Corp. (OTC: CHNC) www.thechnc.com Announces That it has Acquired Houston, TX-Based Hippocrates Direct Healthcare, Inc. as a Wholly-Owned Subsidiary, Through a Reverse Merger
July 24, 2018